SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Wells Fargo Raises Viridian Therapeutics Price Target to $34 From $31

Valid market news retained in the public archive without immediate LiveCast distribution.

VRDN

Related stories